RKSG Among Growth ETFs
End-of-day Nov 18, 2026 · 92 Growth ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.5% | −3.7% | −4.4% | −3.2% | — | — | — | — | — | +10.5% |
| Peer average | +0.3% | −4.6% | −7.5% | −7.9% | −0.2% | +3.4% | +63.7% | +42.9% | +343.4% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$90 of every $1,000 in RKSG is Apple
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | AAPLApple | Technology | 8.96% | $895.76 | 710 | $250K |
| 2 | NVDANvidia | Technology | 7.58% | $757.98 | 1,360 | $211K |
| 3 | MSFTMicrosoft | Technology | 5.17% | $517.25 | 285 | $144K |
| 4 | GOOGLAlphabet | Communication Services | 4.87% | $487.20 | 485 | $136K |
| 5 | LLYEli Lilly | Healthcare | 4.31% | $431.37 | 85 | $120K |
| 6 | AMZNAmazon | Consumer Cyclical | 3.24% | $323.60 | 350 | $90K |
| 7 | METAMETA Platforms | Communication Services | 2.22% | $221.87 | 100 | $62K |
| 8 | AVGOBroadcom | Technology | 2.14% | $214.32 | 175 | $60K |
| 9 | JNJJohnson & Johnson | Healthcare | 2.05% | $204.83 | 205 | $57K |
| 10 | MRKMerck | Healthcare | 1.93% | $192.75 | 375 | $54K |
| 11 | ABBVAbbVie | Healthcare | 1.89% | $188.96 | 180 | $53K |
| 12 | KOCoca-Cola /The | Consumer Defensive | 1.65% | $164.69 | 465 | $46K |
| 13 | LMTLockheed Martin | Industrials | 1.59% | $158.73 | 75 | $44K |
| 14 | REGNRegeneron Pharmaceuticals | Healthcare | 1.55% | $154.51 | 45 | $43K |
| 15 | ALLAllstate /The | Financial Services | 1.50% | $150.28 | 155 | $42K |
Not enough history yet: RKSG needs a year of prices.
RKSG does not pay a distribution.
of the $540B in 113 Growth ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | AAPL | Apple | 8.96% |
| 2 | NVDA | Nvidia | 7.58% |
| 3 | MSFT | Microsoft | 5.17% |
| 4 | GOOGL | Alphabet | 4.87% |
| 5 | LLY | Eli Lilly & | 4.31% |
| 6 | AMZN | Amazon | 3.24% |
| 7 | META | META Platforms | 2.22% |
| 8 | AVGO | Broadcom | 2.14% |
| 9 | JNJ | Johnson & Johnson | 2.05% |
| 10 | MRK | Merck & | 1.93% |
Estimated yearly cost excludes trading costs and assumes constant assets.
No payouts on record: […]